Systematic review: Effect of alcohol intake on adherence to outpatient medication regimens for chronic diseases

Journal of Studies on Alcohol and Drugs

Volumn 73, Issue 6, 2012, Pages 899-910

  Grodensky, Catherine A ^a   Golin, Carol E ^a,b,c   Ochtera, Rebecca D ^b   Turner, Barbara J ^d,e,f  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b University of North Carolina at Chapel Hill   (United States)

^c UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^e San Antonio Campus   (United States)

^f Center for Research to Advance Community Health   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84867586668     PISSN: 19371888     EISSN: 19384114     Source Type: Journal    
DOI: 10.15288/jsad.2012.73.899     Document Type: Article

References (89)

1. Ahmed, A. T., Karter, A. J., & Liu, J. (2006). Alcohol consumption is inversely associated with adherence to diabetes self-care behaviours. Diabetic Medicine, 23, 795-802.
2. Aidala, A., Havens, J., Mellins, C. A., Dodds, S., Whetten, K., Martin, D.,. Ko, P. (2004). Development and validation of the Client Diagnostic Questionnaire (CDQ): A mental health screening tool for use in HIV/AIDS service settings. Psychology, Health & Medicine, 9, 362-380.
3. Akincigil, A., Bowblis, J. R., Levin, C., Walkup, J. T., Jan, S., & Crystal, S.(2007). Adherence to antidepressant treatment among privately insured patients diagnosed with depression. Medical Care, 45, 363-369.
4. Applebaum, A. J., Richardson, M. A., Brady, S. M., Brief, D. J., & Keane, T. M. (2009). Gender and other psychosocial factors as predictors of adherence to highly active antiretroviral therapy (HAART) in adults with comorbid HIV/AIDS, psychiatric and substance-related disorder. AIDS and Behavior, 13, 60-65.
5. Arnsten, J. H., Demas, P. A., Grant, R. W., Gourevitch, M. N., Farzadegan, H., Howard, A. A., & Schoenbaum, E. E. (2002). Impact of active drug use on antiretroviral therapy adherence and viral suppression in HIV-infected drug users. Journal of General Internal Medicine, 17, 377-381.
6. Azar, M. M., Springer, S. A., Meyer, J. P., & Altice, F. L. (2010). A sys-tematic review of the impact of alcohol use disorders on HIV treatment outcomes, adherence to antiretroviral therapy and health care utilization. Drug and Alcohol Dependence, 112, 178-193.
7. Baca-Garcia, E., Sher, L., Perez-Rodriguez, M. M., Burke, A. K., Sullivan, G. M., Grunebaum, M. F.,. Oquendo, M. A. (2009). Treatment of depressed bipolar patients with alcohol use disorders: Plenty of room for improvement. Journal of Affective Disorders, 115, 262-268.
8. Berg, K. M., Demas, P. A., Howard, A. A., Schoenbaum, E. E., Gourevitch, M. N., & Arnsten, J. H. (2004). Gender differences in factors associated with adherence to antiretroviral therapy. Journal of General Internal Medicine, 19, 1111-1117.
9. Beyene, K. A., Gedif, T., Gebre-Mariam, T., & Engidawork, E. (2009). Highly active antiretroviral therapy adherence and its determinants in selected hospitals from south and central Ethiopia. Pharmacoepidemiol-ogy and Drug Safety, 18, 1007-1015.
10. Bonolo, P. de F., César, C. C., Acúrcio, F. A., Ceccato, M. das G. B., de Pádua, C. A. M., Álvares, J.,. Guimarães, M. D. C. (2005). Non-adherence among patients initiating antiretroviral therapy: A challenge for health professionals in Brazil. AIDS, 19, Supplement 4, S5-S13.
11. Bouhnik, A.-D., Chesney, M., Carrieri, P., Gallais, H., Moreau, J., Moatti, J.-P.,. MANIF 2000 Study Group (2002). Nonadherence among HIV-infected injecting drug users: The impact of social instability. Journal of Acquired Immune Deficiency Syndromes, 31, S149-S153.
12. Braithwaite, R. S., Conigliaro, J., McGinnis, K. A., Maisto, S. A., Bryant, K., & Justice, A. C. (2008). Adjusting alcohol quantity for mean con-sumption and intoxication threshold improves prediction of nonadher-ence in HIV patients and HIV-negative controls. Alcoholism: Clinical and Experimental Research, 32, 1645-1651.
13. Braithwaite, R. S., McGinnis, K. A., Conigliaro, J., Maisto, S. A., Crystal, S., Day, N.,. Justice, A. C. (2005). A temporal and dose-response association between alcohol consumption and medication adherence among veterans in care. Alcoholism: Clinical and Experimental Re-search, 29, 1190-1197.
14. Bryson, C. L., Au, D. H., Sun, H., Williams, E. C., Kivlahan, D. R., & Bradley, K. A. (2008). Alcohol screening scores and medication nonad-herence. Annals of Internal Medicine, 149, 795-804.
15. Campos, L. N., Guimarães, M. D. C., & Remien, R. H. (2010). Anxiety and depression symptoms as risk factors for non-adherence to antiretroviral therapy in Brazil. AIDS and Behavior, 14, 289-299.
16. Cantrell, C. R., Priest, J. L., Cook, C. L., Fincham, J., & Burch, S. P. (2011). Adherence to treatment guidelines and therapeutic regimens: A US claims-based benchmark of a commercial population. Population Health Management, 14, 33-41.
17. Centers for Disease Control and Prevention. (2009). Summary health statistics for U.S. adults: National Health Interview Survey, 2008. Vital and Health Statistics, Series 10, Number 242 (DHHS Pub. No. (PHS) 2010-1570). Hyattsville, MD: Author. Retrieved from http://www.cdc.gov/nchs/data/series/sr_10/sr10_242.pdf
18. Centers for Disease Control and Prevention. (2011). CDC health disparities and inequalities report-United States, 2011. Morbidity and Mortality Weekly Report, 60, Supplement, 1-114. Retrieved from www.cdc.gov/mmwr/pdf/other/su6001.pdf
19. Chander, G., Lau, B., & Moore, R. D. (2006). Hazardous alcohol use: A risk factor for non-adherence and lack of suppression in HIV infection. Journal of Acquired Immune Deficiency Syndromes, 43, 411-417.
20. Chesney, M. A., Ickovics, J. R., Chambers, D. B., Gifford, A. L., Neidig, J., Zwickl, B., & Wu, A. W., & the Patient Care Committee & Adherence Working Group of the Outcomes Committee of the Adult AIDS Clinical Trials Group (AACTG). (2000). Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: The AACTG adherence instruments. AIDS Care: Psychological and Socio-medical Aspects of AIDS/HIV, 12, 255-266.
21. Cohn, S. E., Umbleja, T., Mrus, J., Bardeguez, A. D., Andersen, J. W., & Chesney, M. A. (2008). Prior illicit drug use and missed prenatal vitamins predict nonadherence to antiretroviral therapy in pregnancy: Adherence analysis A5084. AIDS Patient Care and STDs, 22, 29-40.
22. Conen, A., Fehr, J., Glass, T. R., Furrer, H., Weber, R., Vernazza, P.,. Battegay, M., & the Swiss HIV Cohort Study. (2009). Self-reported alcohol consumption and its association with adherence and outcome of antiretroviral therapy in the Swiss HIV Cohort Study. Antiviral Therapy, 14, 349-357.
23. Cook, R. L., Sereika, S. M., Hunt, S. C., Woodward, W. C., Erlen, J. A., & Conigliaro, J. (2001). Problem drinking and medication adherence among persons with HIV infection. Journal of General Internal Medi-cine, 16, 83-88.
24. Cox, W. M., Blount, J. P., Crowe, P. A., & Singh, S. P. (1996). Diabetic patients' alcohol use and quality of life: Relationships with prescribed treatment compliance among older males. Alcoholism: Clinical and Experimental Research, 20, 327-331.
25. de Jong, B. C., Prentiss, D., McFarland, W., Machekano, R., & Israelski, D. M. (2005). Marijuana use and its association with adherence to antiret-roviral therapy among HIV-infected persons with moderate to severe nausea. JAIDS Journal of Acquired Immune Deficiency Syndromes, 38, 43-46.
26. DiMatteo, M. R. (2004). Variations in patients' adherence to medical rec-ommendations: A quantitative review of 50 years of research. Medical Care, 42, 200-209.
27. Duran, S., Savès, M., Spire, B., Cailleton, V., Sobel, A., Carrieri, P.,. Leport, C., & the APROCO Study Group. (2001a). Failure to maintain long-term adherence to highly active antiretroviral therapy: the role of lipodystrophy. AIDS, 15, 2441-2444.
28. Duran, S., Spire, B., Raffi, F., Walter, V., Bouhour, D., Journot, V.,. Moatti, J.-P. (2001b). Self-reported symptoms after initiation of a pro-tease inhibitor in HIV-infected patients and their impact on adherence to HAART. HIV Clinical Trials, 2, 38-45.
29. Eigenbrodt, M. L., Mosley, T. H., Jr., Hutchinson, R. G., Watson, R. L., Chambless, L. E., & Szklo, M. (2001). Alcohol consumption with age: A cross-sectional and longitudinal study of the Atherosclerosis Risk in Communities (ARIC) study, 1987-1995. American Journal of Epide-miology, 153, 1102-1111.
30. Friedman, M. S., Marshal, M. P., Stall, R., Kidder, D. P., Henny, K. D., Courtenay-Quirk, C., Holtgrave, D. R. (2009). Associations between substance use, sexual risk taking and HIV treatment adherence among homeless people living with HIV. AIDS Care: Psychological and Socio-medical Aspects of AIDS/HIV, 21, 692-700.
31. Galvan, F. H., Bing, E. G., Fleishman, J. A., London, A. S., Caetano, R., Burnam, M. A.,. Shapiro, M. (2002). The prevalence of alcohol consumption and heavy drinking among people with HIV in the United States: Results from the HIV cost and services utilization study. Journal of Studies on Alcohol, 63, 179-186.
32. Golin, C. E., Liu, H., Hays, R. D., Miller, L. G., Beck, C. K., Ickovics, J., Wenger, N. S. (2002). A prospective study of predictors of adherence to combination antiretroviral medication. Journal of General Internal Medicine, 17, 756-765.
33. Gossec, L., Tubach, F., Dougados, M., & Ravaud, P. (2007). Reporting of adherence to medication in recent randomized controlled trials of 6 chronic diseases: A systematic literature review. American Journal of the Medical Sciences, 334, 248-254.
34. Grenard, J. L., Munjas, B. A., Adams, J. L., Suttorp, M., Maglione, M., McGlynn, E. A., & Gellad, W. F. (2011). Depression and medication adherence in the treatment of chronic diseases in the United States: A meta-analysis. Journal of General Internal Medicine, 26, 1175-1182.
35. Halkitis, P. N., Kutnick, A. H., & Slater, S. (2005). The social realities of adherence to protease inhibitor regimens: Substance use, health care and psychological states. Journal of Health Psychology, 10, 545-558.
36. Halkitis, P. N., Parsons, J. T., Wolitski, R. J., & Remien, R. H. (2003). Characteristics of HIV antiretroviral treatments, access and adherence in an ethnically diverse sample of men who have sex with men. AIDS Care, 15, 89-102.
37. Hankó, B., Kázmér, M., Kumli, P., Hrágyel, Z., Samu, A., Vincze, Z., & Zelkó, R. (2007). Self-reported medication and lifestyle adherence in Hungarian patients with Type 2 diabetes. Pharmacy World & Science, 29, 58-66.
38. Heckman, B. D., Catz, S. L., Heckman, T. G., Miller, J. G., & Kalichman, S. C. (2004). Adherence to antiretroviral therapy in rural persons living with HIV disease in the United States. AIDS Care, 16, 219-230.
39. Hendershot, C. S., Stoner, S. A., Pantalone, D. W., & Simoni, J. M. (2009). Alcohol use and antiretroviral adherence: Review and meta-analysis. Journal of Acquired Immune Deficiency Syndromes, 52, 180-202.
40. Holmes, W. C., Bilker, W. B., Wang, H., Chapman, J., & Gross, R. (2007). HIV/AIDS-specific quality of life and adherence to antiretroviral therapy over time. JAIDS Journal of Acquired Immune Deficiency Syndromes, 46, 323-327.
41. Howard, A. A., Arnsten, J. H., Lo, Y., Vlahov, D., Rich, J. D., Schuman, P.,. Schoenbaum, E. E., & the HER Study Group. (2002). A prospec-tive study of adherence and viral load in a large multi-center cohort of HIV-infected women. AIDS, 16, 2175-2182.
42. Ingersoll, K. (2004). The impact of psychiatric symptoms, drug use, and medication regimen on non-adherence to HIV treatment. AIDS Care, 16, 199-211.
43. Ingersoll, K. S., & Cohen, J. (2008). The impact of medication regimen fac-tors on adherence to chronic treatment: A review of literature. Journal of Behavioral Medicine, 31, 213-224.
44. Johnson, K. H., Bazargan, M., & Bing, E. G. (2000). Alcohol consumption and compliance among inner-city minority patients with type 2 diabetes mellitus. Archives of Family Medicine, 9, 964-970.
45. Johnson, M. O., Catz, S. L., Remien, R. H., Rotheram-Borus, M. J., Morin, S. F., Charlebois, E.,. Chesney, M. A., & the NIMH Healthy Living Project Team. (2003). Theory-guided, empirically supported avenues for intervention on HIV medication nonadherence: findings from the Healthy Living Project. AIDS Patient Care and STDs, 17, 645-656.
46. Kalichman, S. C., Amaral, C. M., White, D., Swetsze, C., Pope, H., Kali-chman, M. O., Eaton, L. (2009). Prevalence and clinical implications of interactive toxicity beliefs regarding mixing alcohol and antiretroviral therapies among people living with HIV/AIDS. AIDS Patient Care and STDs, 23, 449-454.
47. Kilbourne, A. M., Reynolds, C. F., III, Good, C. B., Sereika, S. M., Justice, A. C., & Fine, M. J. (2005). How does depression influence diabetes medication adherence in older patients? American Journal of Geriatric Psychiatry, 13, 202-210.
48. Kim, M. T., Han, H. R., Hill, M. N., Rose, L., & Roary, M. (2003). Depres-sion, substance use, adherence behaviors, and blood pressure in urban hypertensive black men. Annals of Behavioral Medicine, 26, 24-31.
49. Klatsky, A. L., Gunderson, E. P., Kipp, H., Udaltsova, N., & Friedman, G. D. (2006). Higher prevalence of systemic hypertension among moderate alcohol drinkers: An exploration of the role of underreporting. Journal of Studies on Alcohol, 67, 421-428.
50. Kripalani, S., Yao, X., & Haynes, R. B. (2007). Interventions to enhance medication adherence in chronic medical conditions: A systematic review. Archives of Internal Medicine, 167, 540-550.
51. Lazo, M., Gange, S. J., Wilson, T. E., Anastos, K., Ostrow, D. G., Witt, M. D., & Jacobson, L. P. (2007). Patterns and predictors of changes in adherence to highly active antiretroviral therapy: Longitudinal study of men and women. Clinical Infectious Diseases, 45, 1377-1385.
52. Lerman, I., Lozano, L., Villa, A. R., Hernández-Jiménez, S., Weinger, K., Caballero, A. E., Rull, J. A. (2004). Psychosocial factors associated with poor diabetes self-care management in a specialized center in Mexico City. Biomedicine & Pharmacotherapy, 58, 566-570.
53. Leserman, J., Ironson, G., O'Cleirigh, C., Fordiani, J. M., & Balbin, E. (2008). Stressful life events and adherence in HIV. AIDS Patient Care and STDs, 22, 403-411.
54. Liu, H., Longshore, D., Williams, J. K., Rivkin, I., Loeb, T., Warda, U. S., Wyatt, G. (2006). Substance abuse and medication adherence among HIV-positive women with histories of child sexual abuse. AIDS and Behavior, 10, 279-286.
55. Martini, M., Recchia, E., Nasta, P., Castanotto, D., Chiaffarino, F., Parazzini, F., & Agnoletto, V. (2004). Illicit drug use: Can it predict adherence to antiretroviral therapy? European Journal of Epidemiology, 19, 585-587.
56. Mayfield, D., McLeod, G., & Hall, P. (1974). The CAGE questionnaire: Validation of a new alcoholism screening instrument. American Journal of Psychiatry, 131, 1121-1123.
57. McDonnell Holstad, M. K., Pace, J. C., De, A. K., & Ura, D. R. (2006). Factors associated with adherence to antiretroviral therapy. Journal of the Association of Nurses in AIDS Care, 17, 4-15.
58. McGlynn, E. A., Asch, S. M., Adams, J., Keesey, J., Hicks, J., DeCristofaro, A., & Kerr, E. A. (2003). The quality of health care delivered to adults in the United States. The New England Journal of Medicine, 348, 2635-2645.
59. McLellan, A. T., Luborsky, L., Woody, G. E., & O'Brien, C. P. (1980). An improved diagnostic evaluation instrument for substance abuse patients: The Addiction Severity Index. Journal of Nervous & Mental Disease, 168, 26-33.
60. Mellins, C. A., Havens, J. F., McDonnell, C., Lichtenstein, C., Uldall, K., Chesney, M., Bell, C. (2009). Adherence to antiretroviral medica-tions and medical care in HIV-infected adults diagnosed with mental and substance abuse disorders. AIDS Care Psychological and Socio-medical Aspects of AIDS/HIV, 21, 168-177.
61. Miller, W. R., Tonigan, J. S., & Longabaugh, R. (1995). The drinker inven-tory of consequences (DrInC): An instrument for assessing adverse con-sequences of alcohol abuse: Test manual (Project MATCH Monograph Series, Vol. 4, NIH Publication No. 95-3911). Rockville, MD: National Institute on Alcohol Abuse and Alcoholism.
62. Millon, T., Davis, R. D., & Millon, C. M. (1996). Disorders of personality: DSM-IV and beyond. New York, NY: Wiley.
63. Moatti, J. P., Carrieri, M. P., Spire, B., Gastaut, J. A., Cassuto, J. P., & Moreau, J,. & the Manif 2000 study group. (2000). Adherence to HAART in French HIV-infected injecting drug users: The contribution of buprenorphine drug maintenance treatment. AIDS, 14, 151-155.
64. Mugavero, M., Ostermann, J., Whetten, K., Leserman, J., Swartz, M., Stangl, D., & Thielman, N. (2006). Barriers to antiretroviral adherence: The importance of depression, abuse, and other traumatic events. AIDS Patient Care and STDs, 20, 418-428.
65. Murphy, D. A., Marelich, W. D., Hoffman, D., & Steers, W. N. (2004). Pre-dictors of antiretroviral adherence. AIDS Care, 16, 471-484.
66. National Institute on Alcohol Abuse and Alcoholism. (2005). Helping pa-tients who drink too much: A clinician's guide. Washington, DC: Author.
67. Osterberg, L., & Blaschke, T. (2005). Adherence to medication. The New England Journal of Medicine, 353, 487-497.
68. Reeves, B. C., Deeks, J. J., Higgins, J. P. T., & Wells, G. A., on behalf of the Cochrane Non-Randomised Studies Methods Group. (2008). Chapter 13: Including non-randomized studies. In: J. P. T. Higgins & S. Green (Eds.), Cochrane handbook for systematic reviews of interventions. Version 5.0.1 [updated September 2008]. The Cochrane Collabora-tion. Retrieved from http://hiv.cochrane.org/sites/hiv.cochrane.org/files/uploads/Ch13_NRS.pdf
69. Parsons, J. T., Rosof, E., & Mustanski, B. (2007). Patient-related factors pre-dicting HIV medication adherence among men and women with alcohol problems. Journal of Health Psychology, 12, 357-370.
70. Peretti-Watel, P., Spire, B., Lert, F., & Obadia, Y. (2006). Drug use patterns and adherence to treatment among HIV-positive patients: Evidence from a large sample of French outpatients. Drug and Alcohol Dependence, 82, S71-S79.
71. Protopopescu, C., Raffi, F., Roux, P., Reynes, J., Dellamonica, P., Spire, B.,. Carrieri, M.-P., & on behalf of the ANRS CO8 (APROCO-CO-PILOTE) Study Group (2009). Factors associated with non-adherence to long-term highly active antiretroviral therapy: A 10 year follow-up analysis with correction for the bias induced by missing data. Journal of Antimicrobial Chemotherapy, 64, 599-606.
72. Rothlind, J. C., Greenfield, T. M., Bruce, A. V., Meyerhoff, D. J., Flenniken, D. L., Lindgren, J. A., & Weiner, M. W. (2005). Heavy alcohol consump-tion in individuals with HIV infection: Effects on neuropsychological performance. Journal of the International Neuropsychological Society, 11, 70-83.
73. Roux, P., Carrieri, M. P., Michel, L., Fugon, L., Marcellin, F., Obadia, Y., & Spire, B. (2009). Effect of anxiety symptoms on adherence to highly active antiretroviral therapy in HIV-infected women. Journal of Clinical Psychiatry, 70, 1328-1329.
74. Safren, S. A., Otto, M. W., Worth, J. L., Salomon, E., Johnson, W., Mayer, K., & Boswell, S. (2001). Two strategies to increase adherence to HIV antiretroviral medication: Life-Steps and medication monitoring. Behav-iour Research and Therapy, 39, 1151-1162.
75. Samet, J. H., Horton, N. J., Meli, S., Freedberg, K. A., & Palepu, A. (2004). Alcohol consumption and antiretroviral adherence among HIV-infected persons with alcohol problems. Alcoholism: Clinical and Experimental Research, 28, 572-577.
76. Saunders, J. B., Aasland, O. G., Babor, T. F., de la Fuente, J. R., & Grant, M. (1993). Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO collaborative project on early detection of persons with harmful alcohol consumption-II. Addiction, 88, 791-804.
77. Silva, M. C. F., Ximenes, R. A. A., Filho, D. B. M., Arraes, L. W. M. S., Mendes, M., Melo, A. C. S., & Fernandes, P. R. M. (2009). Risk-factors for non-adherence to antiretroviral therapy. Revista do Instituto de Me-dicina Tropical de São Paulo, 51, 135-139.
78. Skinner, H. A. (1979). Lifetime drinking history: Administration and scoring guidelines. Toronto, Canada: Addiction Research Foundation.
79. Sobell, L.C., & Sobell, M.B., (1992). Timeline followback: A technique for assessing self-reported alcohol consumption. In R. Z. Litten & J. Allen (Eds.), Measuring alcohol consumption: Psychosocial and biological methods (pp. 41-72). Totowa, NJ: Humana Press.
80. Spire, B., Duran, S., Souville, M., Leport, C., Raffi, F., & Moatti, J. P., & the APROCO cohort study group. (2002). Adherence to highly active anti-retroviral therapies (HAART) in HIV-infected patients: From a predic-tive to a dynamic approach. Social Science & Medicine, 54, 1481-1496.
81. Stampfer, M. J., Kang, J. H., Chen, J., Cherry, R., & Grodstein, F. (2005). Effects of moderate alcohol consumption on cognitive function in women. The New England Journal of Medicine, 352, 245-253.
82. Sullivan, P. S., Campsmith, M. L., Nakamura, G. V., Begley, E. B., Schul-den, J., & Nakashima, A. K. (2007). Patient and regimen characteristics associated with self-reported nonadherence to antiretroviral therapy. PLoS ONE, 2(6), e552. Retrieved from http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0000552
83. Theall, K. P., Clark, R. A., Powell, A., Smith, H., & Kissinger, P. (2007). Alcohol consumption, ART usage and high-risk sex among women infected with HIV. AIDS and Behavior, 11, 205-215.
84. Turner, B. J. (2009). Gaps in addressing problem drinking: Overcoming primary care and alcohol treatment deficiencies. Current Psychiatry Reports, 11, 345-352.
85. Waldrop-Valverde, D., Ownby, R. L., Wilkie, F. L., Mack, A., Kumar, M., & Metsch, L. (2006). Neurocognitive aspects of medication adherence in HIV-positive injecting drug users. AIDS and Behavior, 10, 287-297.
86. Waldrop-Valverde, D., & Valverde, E. (2005). Homelessness and psy-chological distress as contributors to antiretroviral nonadherence in HIV-positive injecting drug users. AIDS Patient Care and STDs, 19, 326-334.
87. Wang, P. S., Bohn, R. L., Knight, E., Glynn, R. J., Mogun, H., & Avorn, J. (2002). Noncompliance with antihypertensive medications: the impact of depressive symptoms and psychosocial factors. Journal of General Internal Medicine, 17, 504-511.
88. Wang, X., & Wu, Z. (2007). Factors associated with adherence to antiret-roviral therapy among HIV/AIDS patients in rural China. AIDS, 21, Supplement 8, S149-S155.
89. Wells, G. A., Shea, B., O'Connell, D., Peterson, J., Welch, V., Losos, M., & Tugwell, P. (1999). The Newcastle-Ottawa scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Ottawa, Ontario: Ottawa Health Research Institute.